Kenneth B. Wells, M.D., M.P.H. (Chair), is the director of the Center for Health Services and Society at the Jane and Terry Semel Institute for Neuroscience and Human Behavior of the University of California, Los Angeles (UCLA), and the David Weil Professor of Psychiatry and Biobehavioral Sciences at the UCLA David Geffen School of Medicine and the Department of Health Policy and Management in the Fielding School of Public Health. He is affiliated adjunct staff at the RAND Corporation and a staff psychiatrist at the West Los Angeles branch of the Department of Veterans Affairs. His research interests are in integrating evidence-based practices with community-partnered participatory research approaches to address behavioral health disparities and social determinants of health. He received his A.B. from Occidental College, his M.D. from the University of California, San Francisco, and his M.P.H. from UCLA. Dr. Wells is a member of the National Academy of Medicine.
Hortensia Amaro, Ph.D. (Vice Chair), is a Distinguished University Professor and a Senior Scholar on Community Health at the Herbert Wertheim College of Medicine and the Robert Stempel College of Public Health & Social Work at Florida International University. She previously served as an associate vice provost and the Dean’s Professor at the University of Southern California, a distinguished professor and an associate dean at the Northeastern University Bouvé College of Health Sciences, and a professor at the Boston University School of Public Health. Dr. Amaro founded five programs for treatment of substance use disorders (SUDs)
among disenfranchised minority women—including pregnant and postpartum women and women returning from incarceration—in Boston. She served as the vice chair of the board of the Boston Public Health Commission and on review and advisory committees to the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, and the Centers for Disease Control and Prevention and as a consultant on SUDs for the Department of State’s Latin America programs. Dr. Amaro’s research focuses on alcohol and drug use among adolescents and adults; treatment of SUD, mental health disorders, and trauma among minority women; alcohol and drug use among college populations; and the development and testing of gender-specific behavioral interventions for HIV/AIDS prevention. She received her Ph.D. in psychology from the University of California, Los Angeles. Dr. Amaro is a member of the National Academy of Medicine.
Gina Bryan, D.N.P., PMHCNS-BC, APRN, is a clinical professor and the director of the postgraduate psychiatry program at the University of Wisconsin–Madison School of Nursing. She teaches in the graduate nursing and pharmacy programs. In addition, Dr. Bryan maintains an active clinical practice in community psychiatry at Rock County Mental Health. She was a partner on a Substance Abuse and Mental Health Services Administration Screening, Brief Intervention, and Referral to Treatment training grant. Dr. Bryan also serves on the Wisconsin Commission on Substance Abuse Treatment Delivery to research hub-and-spoke delivery models for opioid treatment and identify key implementation considerations. Her scholarly interests are currently focused on novel health care provider collaborations to improve access to medications for substance use disorders. Dr. Bryan earned her B.S.N, M.S., and D.N.P. from the University of Wisconsin–Madison.
Karen Cropsey, Psy.D., is a licensed clinical psychologist and the Conaster Turner Endowed Professor of Psychiatry at the University of Alabama at Birmingham School of Medicine. Dr. Cropsey is also a certified forensic evaluator. She was previously the director of mental health for the Mississippi Department of Corrections. Dr. Cropsey’s research interests include treatment interventions for correctional and other disenfranchised populations with substance use disorders (SUDs), with a particular focus on opioid treatment interventions. She has conducted several studies investigating the treatment of opioid dependence in criminal justice and HIV-infected populations. Her laboratory conducts clinical research trials on SUD treatment, developing and testing novel therapeutics, behavioral techniques, and technology interventions. This includes a study on training and distributing naloxone kits in the community. Dr. Cropsey com-
pleted her M.S. at the University of Wisconsin–Madison and her Psy.D. at Indiana State University.
Joan Duwve, M.D., M.P.H., is an associate professor in health policy and management and the associate dean of public health practice at the Indiana University Richard M. Fairbanks School of Public Health, as well as the founder of the Center for Public Health Practice and the director of the Extension for Community Healthcare Outcomes center at the school of public health (training providers across the state to treat patients with hepatitis C). She is currently involved with studies on injection drug use, transmission of HIV and hepatitis C virus among people who inject drugs, and prevention of opioid overdoses. Before joining Indiana University, Dr. Duwve was the medical director of public health preparedness at the Indiana State Department of Health and then the chief medical officer. In these positions, she co-chaired the state Prescription Drug Prevention Task Force, which drafted opioid prescribing legislation, and supported the injury prevention program (including first responder naloxone training and county leader education about medications for opioid use disorder), HIV and sexually transmitted infections prevention, and other epidemiological programs. Dr. Duwve is board certified in family medicine. She received her M.D. from Johns Hopkins University and her M.P.H. from the University of Michigan.
Rahul Gupta, M.D., M.P.H., M.B.A., FACP, is the senior vice president and the chief medical and health officer at March of Dimes. He provides strategic oversight for March of Dimes medical and public health efforts to improve the health of all mothers and babies. Before joining March of Dimes, Dr. Gupta was the West Virginia State Chief Health Officer. As the public health commissioner, he led the state’s opioid crisis response and launched a number of pioneering public health initiatives, such as the Birthscore program to identify high-risk infants. Dr. Gupta, a specialist in internal medicine and preventive medicine, served as academic faculty in Tennessee and Alabama before going to West Virginia originally in 2009 to lead the Kanawha-Charleston Health Department. He is also an adjunct professor in the Department of Health Policy, Management & Leadership in the School of Public Health at West Virginia University and holds several other academic appointments. Throughout his career, Dr. Gupta has served as an advisor to nonprofit organizations and task forces on local, national, and international public health policy and programs. He received his M.D. from the University of Delhi, his M.P.H. from the University of Alabama at Birmingham, and his M.B.A. from the London School of Business and Finance.
David H. Gustafson, Ph.D., directs the University of Wisconsin−Madison’s Center for Health Enhancement Systems Studies. His research interests focus on developing systems engineering tools to support sustainable individual and organizational change and improvement in addiction, cancer, and aging. The Network for Improvement of Addiction Treatment grew to more than 3,000 addiction treatment agencies and has conducted nationwide experiments to test the effectiveness of quality improvement models to enhance access to and retention in addiction treatment. His individual change research develops and tests computer systems (Center for Health Enhancement Systems Studies [CHESS]) to help people deal with serious illness. The addiction program, ACHESS, has been used by more than 6,000 patients; in randomized trials, it reduced risky drinking and improved retention in treatment and abstinence. Other versions of CHESS have improved outcomes in areas such as HIV, asthma, and breast, lung, and colon cancer. Dr. Gustafson has produced models to predict and explain implementation, sustainability, and diffusion of innovations and to measure quality of care and understand customer needs. He co-chaired the federal Science Panel on Interactive Communications in Health, served on several National Institutes of Health Study Sections, and is a member of the Substance Abuse and Mental Health Services Administration National Advisory Council. Dr. Gustafson is a fellow of the Association for Health Services Research, the American Medical Informatics Association, the W.K. Kellogg Foundation, and the Institute for Healthcare Improvement; he co-founded and was the board vice chair of the latter. Dr. Gustafson holds an M.S. and a Ph.D. from the University of Michigan. He is a member of the National Academy of Engineering.
Marcela Horvitz-Lennon, M.D., M.P.H., is a senior physician scientist at the RAND Corporation, a core faculty member of the Pardee RAND Graduate School, and a member of the faculty in psychiatry at Harvard Medical School. She is also a practicing psychiatrist at Cambridge Health Alliance. Much of her research is on the quality and value of health care received by adults with serious mental illnesses, with a focus on public payers. Dr. Horvitz-Lennon has conducted research on health care program evaluation; racial/ethnic and geographic disparities in care; Medicaid and federal health care policy; underuse and overuse of mental health interventions; integration of physical and mental health care; diffusion of mental health innovations; and global mental health. Her recent projects include an evaluation of the Substance Abuse and Mental Health Services Administration primary and behavioral health care integration grant program. Dr. Horvitz-Lennon earned her M.D. in Chile and her M.P.H. at Johns Hopkins University.
Raymond C. Love, Pharm.D., BCPP, FASHP, is a professor of pharmacy and psychiatry at the University of Maryland. He directs the State of Maryland Mental Health Pharmacy Program, coordinates the Maryland Statewide Pharmacy and Therapeutics Committee, and participates in planning mental health pharmacy services and systems at various levels of state government. This work has resulted in introducing a number of innovations, including clinical pharmacy services, psychiatric pharmacotherapy, statewide data tracking, drug use analysis, educational programs, and community partnerships. In addition, Dr. Love co-directs the Center for Addiction Research, Education, and Service at the University of Maryland. He earned his Pharm.D. from the University of Maryland.
Yngvild Olsen, M.D., M.P.H., DFASAM, is the medical director of the Institutes for Behavior Resources Inc./Recovery Enhanced by Access to Comprehensive Healthcare Health Services and a consultant on integrated care initiatives in Maryland. She previously served as the vice president of clinical affairs for the Baltimore Substance Abuse Systems, where she played a central role in expanding buprenorphine treatment for opioid addiction in both the treatment and medical systems. Dr. Olsen was also the deputy health officer for the Harford County Health Department, where she oversaw local substance use treatment services, and the medical director for The Johns Hopkins Hospital’s outpatient substance use treatment services. Dr. Olsen has written and lectured extensively on opioid use disorder (OUD) and its treatments, including on treatment programs, the public health impact of buprenorphine treatment expansion, the stigma associated with medications for OUD, and the dual challenges of pain treatment and addiction. Dr. Olsen is the Secretary for the American Society of Addiction Medicine board of directors and the past president of both the Maryland–DC Society of Addiction Medicine and the Maryland Association for the Treatment of Opioid Dependence. Dr. Olsen received her M.D. from Harvard Medical School and her M.P.H. from Johns Hopkins University.
Sharon Reif, Ph.D., is a senior scientist and a lecturer in social policy and management at Brandeis University. She is also the deputy director of the university’s Institute for Behavioral Health. Dr. Reif conducts health services research using survey, interview, and quantitative methods and secondary data analysis to address treatment and quality issues for people with substance use disorders (SUDs). Her research interests include medications for treating addiction, treatment of opioid use disorders, implementation of Screening, Brief Intervention and Referral to Treatment in a community organization serving low-income young adults, and the
impact of health reform and parity on behavioral health service delivery, quality of care, and financing and access to care. Her work has included collaborations with community organizations, communities more broadly, and states, with the use of national datasets. Dr. Reif has prepared a white paper on the opioid crisis and published systematic reviews in the areas of peer support, residential treatment, and housing for people with SUDs. She received her Ph.D. from Brandeis University.